Molecular Partners AG (SWX: MOLN)
Switzerland
· Delayed Price · Currency is CHF
4.800
-0.100 (-2.04%)
Nov 20, 2024, 5:30 PM CET
Molecular Partners AG Employees
Molecular Partners AG had 168 employees as of December 31, 2023. The number of employees decreased by 8 or -4.45% compared to the previous year.
Employees
168
Change (1Y)
-8
Growth (1Y)
-4.45%
Revenue / Employee
35.73K CHF
Profits / Employee
-372.57K CHF
Market Cap
176.94M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Roche Holding AG | 103,605 |
Roche Holding AG | 103,605 |
Novartis AG | 76,057 |
Galderma Group AG | 6,545 |
Galenica AG | 7,902 |
SKAN Group AG | 1,527 |
Basilea Pharmaceutica AG | 147 |
DocMorris AG | 1,453 |
Molecular Partners AG News
- 13 days ago - Molecular Partners Presents Preclinical Proof-of-Concept for CD3 Switch-DARPin T Cell Engager, Clinical Biomarker Analyses for MP0317 at SITC 2024 - GlobeNewsWire
- 20 days ago - Molecular Partners Q3 2024 Interim Management Statement: Multiple Updates Across Portfolio, Radio-DARPin candidate MP0712 preparing for clinical entry, MP0533 Phase 1 on-going - GlobeNewsWire
- 27 days ago - Molecular Partners prices $20M offering - Seeking Alpha
- 27 days ago - Molecular Partners Announces Pricing of $20 Million Underwritten Offering - GlobeNewsWire
- 4 weeks ago - Molecular Partners stock climbs 6% on expanded radiopharmaceuticals deal - Seeking Alpha
- 4 weeks ago - Molecular Partners and Orano Med Present Additional Positive Preclinical Data Supporting DLL3 Targeting Radio-DARPin Therapeutic Candidate MP0712 at EANM 2024 - GlobeNewsWire
- 4 weeks ago - Molecular Partners and Orano Med Strengthen Agreement to Co-Develop 212Pb-Based Radio-DARPin Therapeutics - GlobeNewsWire
- 6 weeks ago - Molecular Partners Announces upcoming poster presentations at the 2024 SITC Annual Meeting - GlobeNewsWire